Macquarie Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-64,170
| Closed | -$26K | – | 1724 |
|
|
2023
Q2 | $26K | Hold |
64,170
| – | – | ﹤0.01% | 1618 |
|
|
2023
Q1 | $26K | Hold |
64,170
| – | – | ﹤0.01% | 1662 |
|
|
2022
Q4 | $28K | Hold |
64,170
| – | – | ﹤0.01% | 1691 |
|
|
2022
Q3 | $18K | Hold |
64,170
| – | – | ﹤0.01% | 2245 |
|
|
2022
Q2 | $23K | Hold |
64,170
| – | – | ﹤0.01% | 2270 |
|
|
2022
Q1 | $43K | Hold |
64,170
| – | – | ﹤0.01% | 2194 |
|
|
2021
Q4 | $83K | Hold |
64,170
| – | – | ﹤0.01% | 1995 |
|
|
2021
Q3 | $139K | Hold |
64,170
| – | – | ﹤0.01% | 1872 |
|
|
2021
Q2 | $175K | Hold |
64,170
| – | – | ﹤0.01% | 1827 |
|
|
2021
Q1 | $167K | Hold |
64,170
| – | – | ﹤0.01% | 1757 |
|
|
2020
Q4 | $178K | Buy |
+64,170
| New | +$187K | ﹤0.01% | 1701 |
|
|
2019
Q2 | – | Sell |
-108,125
| Closed | -$1.15M | – | 1890 |
|
|
2019
Q1 | $1.15M | Buy |
+108,125
| New | +$1.08M | ﹤0.01% | 1144 |
|
Macquarie Group's SIOX Position: Q3 2023 in Review
Macquarie Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2023, closing a stake of 64,170 shares — an estimated $26K sold.
Macquarie Group first reported a position in SIOX in Q1 2019 and held it in 12 quarters. The position peaked at $1.15M in Q1 2019. 0 funds tracked by Wall St. Rank hold SIOX as of Q3 2023.
- Macquarie Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Macquarie Group sold 64,170 Sio Gene Therapies Inc. Common Stock shares in Q3 2023, an estimated $26K.
- Macquarie Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2019 and held it in 12 quarters.
- Macquarie Group's Sio Gene Therapies Inc. Common Stock position peaked at $1.15M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2023.
Based on Macquarie Group's 13F filing for Q3 2023, filed 14 Nov 2023.